New Findings Offer Improved Therapy for Early-Stage, BRCA Mutation-Associated Breast Cancer

New treatment demonstrates it has the potential to improve the outcomes for patients with hereditary BRCA mutations

New high-throughput analytic enables differentiation of tumor cells within its microenvironment

Experts from the Center for Bioinformatics and Computational Biology have devised a new technology